DK149475C - Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma - Google Patents

Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma

Info

Publication number
DK149475C
DK149475C DK57079A DK57079A DK149475C DK 149475 C DK149475 C DK 149475C DK 57079 A DK57079 A DK 57079A DK 57079 A DK57079 A DK 57079A DK 149475 C DK149475 C DK 149475C
Authority
DK
Denmark
Prior art keywords
plasap
herapin
reagent
determining
biological activity
Prior art date
Application number
DK57079A
Other languages
Danish (da)
English (en)
Other versions
DK57079A (da
DK149475B (da
Inventor
Knut Bartl
Helmut Lill
Joachim Ziegenhorn
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK57079A publication Critical patent/DK57079A/da
Publication of DK149475B publication Critical patent/DK149475B/da
Application granted granted Critical
Publication of DK149475C publication Critical patent/DK149475C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10Anilides
    • C12Q2337/12Para-Nitroanilides p-NA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8114Kunitz type inhibitors
    • G01N2333/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444Factor X (3.4.21.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK57079A 1978-03-23 1979-02-12 Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma DK149475C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2812943 1978-03-23
DE2812943A DE2812943C3 (de) 1978-03-23 1978-03-23 Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma

Publications (3)

Publication Number Publication Date
DK57079A DK57079A (da) 1979-09-24
DK149475B DK149475B (da) 1986-06-23
DK149475C true DK149475C (da) 1986-12-01

Family

ID=6035376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK57079A DK149475C (da) 1978-03-23 1979-02-12 Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma

Country Status (22)

Country Link
US (1) US4234682A (de)
EP (1) EP0004271A3 (de)
JP (1) JPS54128796A (de)
AR (1) AR217503A1 (de)
AT (1) AT362080B (de)
AU (1) AU512206B2 (de)
BE (1) BE875014A (de)
CA (1) CA1111334A (de)
CH (1) CH642749A5 (de)
DD (1) DD141952A5 (de)
DE (1) DE2812943C3 (de)
DK (1) DK149475C (de)
FI (1) FI62859C (de)
FR (1) FR2420764A1 (de)
GB (1) GB2017298B (de)
HU (1) HU176068B (de)
IE (1) IE48067B1 (de)
IT (1) IT1112966B (de)
LU (1) LU81070A1 (de)
NL (1) NL7902259A (de)
SE (1) SE445560B (de)
ZA (1) ZA79622B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903701C2 (de) * 1979-01-31 1980-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Kontrollreagens für die Bestimmung der Heparinaktivität
US4244865A (en) * 1979-12-03 1981-01-13 Abbott Laboratories α hydroxy tripeptide substrates
DE3005540A1 (de) * 1980-02-14 1981-08-20 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagens zur bestimmung der biologischen aktivitaet von heparin im plasma
DE3019612A1 (de) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisiertes thrombinpraeparat
WO1982001377A1 (en) * 1980-10-09 1982-04-29 Lill Helmut Method for determining a bm-antithrombin
US4473639A (en) * 1982-09-15 1984-09-25 Miles Laboratories, Inc. Reagent strip test for antithrombin-III
US4543335A (en) * 1982-12-20 1985-09-24 Miles Laboratories, Inc. Device and method for the quantitative determination of heparin in mammalian blood plasma
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
DE3679763D1 (de) * 1985-09-05 1991-07-18 E Thye Yin Verfahren und zusammensetzungen zur bestimmung von heparin.
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
AU6067190A (en) * 1989-07-20 1991-02-22 Analytical Control Systems, Inc. Improved stable coagulation controls
US5939325A (en) * 1989-07-20 1999-08-17 Analytical Control Systems, Inc. Stable whole blood coagulation controls
WO1992007954A1 (en) * 1990-11-05 1992-05-14 Baxter Diagnostics Inc. A method to determine the concentration of anticoagulants
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
EP1325962A1 (de) * 2001-12-17 2003-07-09 Gentium S.p.A. Methode zur Bestimmung der biologischen Aktivität von Defibrotide
EP1745145A4 (de) * 2004-05-11 2008-03-26 Heptest Lab Inc Zusammensetzung, kit und einstufiges verfahren zur überwachung von verbindungen mit anti-faktor-xa- und/oder anti-faktor-iia-wirkungen
US7219827B2 (en) 2004-11-19 2007-05-22 General Electric Company Braze end isolation layer for generator armature winding bar and method for applying the isolation layer
DE102005038418A1 (de) * 2005-08-12 2007-02-15 Dade Behring Marburg Gmbh Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente
AU2010363814B2 (en) 2010-11-12 2016-05-19 Gentium S.R.L. Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD).
EP2484775A1 (de) 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
CN110079580B (zh) 2012-06-22 2022-12-06 真蒂奥姆责任有限公司 用于测定去纤维蛋白多核苷酸的生物活性的基于优球蛋白的方法
EP2843416A1 (de) 2013-09-02 2015-03-04 Siemens Healthcare Diagnostics Products GmbH Kontroll- und Kalibratormaterial für die Bestimmung von direkten Antikoagulanzien
EP3026122A1 (de) 2014-11-27 2016-06-01 Gentium S.p.A. Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid
EP3348649A1 (de) 2017-01-16 2018-07-18 Siemens Healthcare Diagnostics Products GmbH Universales kontrollmaterial für gerinnungsfaktorinhibitor-teste
EP4703478A1 (de) 2024-08-27 2026-03-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zum ausschluss von faktor xia-inhibitoren in patientenproben

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769617A (en) * 1971-12-09 1973-10-30 Rca Corp Transmission line using a pair of staggered broad metal strips
SE380257B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser
US4162941A (en) * 1974-12-05 1979-07-31 Ab Kabi Method for determining a proteolytic enzyme
CH587439A5 (de) * 1974-12-10 1977-04-29 Daimler Benz Ag
CH622286A5 (de) * 1975-06-23 1981-03-31 Pentapharm Ag
SE407405B (sv) * 1975-07-11 1979-03-26 Kabi Ab Nya kromogena trombinsubstrat
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
DE2601372C3 (de) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zur Bestimmung von Antithrombin III
NL7602423A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Bepaling van heparine in bloedplasma.
US4067777A (en) * 1976-05-13 1978-01-10 Innerfield Irving Determination of heparin in the blood

Also Published As

Publication number Publication date
AU4382579A (en) 1979-09-27
US4234682A (en) 1980-11-18
SE7902555L (sv) 1979-09-24
FR2420764B1 (de) 1983-07-29
FI62859C (fi) 1983-03-10
BE875014A (fr) 1979-09-24
IE48067B1 (en) 1984-09-19
AT362080B (de) 1981-04-27
IT7921220A0 (it) 1979-03-22
AU512206B2 (en) 1980-09-25
IE790238L (en) 1979-09-23
NL7902259A (nl) 1979-09-25
GB2017298A (en) 1979-10-03
LU81070A1 (de) 1979-06-19
IT1112966B (it) 1986-01-20
FI62859B (fi) 1982-11-30
ATA32179A (de) 1980-09-15
DE2812943A1 (de) 1979-10-04
HU176068B (en) 1980-12-28
DK57079A (da) 1979-09-24
JPS5726120B2 (de) 1982-06-02
EP0004271A2 (de) 1979-10-03
JPS54128796A (en) 1979-10-05
EP0004271A3 (de) 1980-04-02
DE2812943C3 (de) 1981-05-14
CA1111334A (en) 1981-10-27
DK149475B (da) 1986-06-23
FR2420764A1 (fr) 1979-10-19
FI790476A7 (fi) 1979-09-24
DE2812943B2 (de) 1980-08-14
GB2017298B (en) 1982-07-07
AR217503A1 (es) 1980-03-31
SE445560B (sv) 1986-06-30
ZA79622B (en) 1980-03-26
DD141952A5 (de) 1980-05-28
CH642749A5 (de) 1984-04-30

Similar Documents

Publication Publication Date Title
DK149475C (da) Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma
DK372178A (da) Fremgangsmaade og reagens til bestemmelse af alfa-amylase
DK315679A (da) Fremgangsmaade og reagens til kvantitativ enzymatisk bestemmelse af adenosindiphosphat
NO163426C (no) Lyseringsreagens og fremgangsmaate ved lysering.
DK544982A (da) Engangsbuks og fremgangsmaade til fremstilling af denne
IT7924560A0 (it) Procedimento e dispositivo per analisi di campioni di sangue intero.
DK158526C (da) Reagens til lipasebestemmelse og fremgangsmaade til fremstilling deraf
ATE10013T1 (de) Verfahren und reagens zur bestimmung von glycerin.
DK160511C (da) Fremgangsmaade og reagens til bestemmelse af antithrombin-bm
DK6179A (da) Fremgangsmaade til fremstilling af prostaglandinderivater og midler indeholdende disse
DK188184D0 (da) Fremgangsmaade til dannelse af et kompleks af biologisk aktive eller funktionelle forbindelser og anvendelse af forbindelserne
DK571978A (da) Fremgangsmaade og reagens til prothrombinbestemmelse
IT7869517A0 (it) Reattivo per la rivelazione e per la determinazione di enzimi
DK576187D0 (da) Fremgangsmaade til bestemmelse af oxygenkoncentration
DK596783D0 (da) Fremgangsmade til bestemmelse af blods eller et blodderivats evne til at koagulere og reagens til brug herved
DK194577A (da) Fremgangsmade til bestemmelse af lipaseaktivetet og reagens til brug herved
DK320279A (da) Fremgangsmaade og reagens til gennemfoerelse af enzymatiske bestemmelser
DK173884A (da) Fremgangsmaade til kvantitativ bestemmelse af haemoglobinkoncentrationen i en biologisk proeve
DK390779A (da) Phosphatpufferoploesninger til kontrol af haemogasanalysatorer og fremgangsmaade til fremstilling af saadanne oploesninger
DK221380A (da) Lipase-bestemmelsesmetode og reagens
ATE4328T1 (de) Verfahren und reagens zur bestimmung von glycerin.
DK205982A (da) Fremgangsmaade og middel til flegmatisering af hydroxy-benzotriazoler hydroxy-oxo-dihydro-benzotriaziner
DK172678A (da) Fremgangsmaade og reagens til bestemmelse af urinsyre
DK154459C (da) Fremgangsmaade og reagens til bestemmelse af creatinkinase-mb
NO802095L (no) Fremgangsmaate og reagenser for blodtypebestemmelse